From One-at-a-Time to Automation and Data Modelling in Media Optimisation 🔄

With the cell and gene therapy industry shifting more towards Industry 4.0, focusing on automation, large-scale data analysis and modelling, and AI, I imagine we're going to see an increasing number of third-party solutions to the media design problem. This should have the flow-on effects of increasing yield and reducing costs - for therapies, for food and for any product developed using biomanufacturing 🌐.